|
2010 Journal Article Gleason scoring: A comparison of classical and modified (International Society of Urological Pathology) criteria using nadir PSA as a clinical end pointDelahunt, Brett, Lamb, David S., Srigley, John R., Murray, Judy D., Wilcox, Chantelle, Samaratunga, Hemamali, Atkinson, Christopher, Spry, Nigel A., Joseph, David and Denham, James W. (2010). Gleason scoring: A comparison of classical and modified (International Society of Urological Pathology) criteria using nadir PSA as a clinical end point. Pathology, 42 (4), 339-343. doi: 10.3109/00313021003787924 |
|
2010 Conference Publication Expression of PSA-RP2, an alternatively spliced variant from the PSA gene, is increased in prostate cancer tissues but the protein is not secreted from prostate cancer cellsWhitbread, Astrid K., Veveris-Lowe, Tara L., Dong, Ying, Tan, Olivia L., Gardiner, Robert, Samaratunga, Hema M., Nicol, David L. and Clements, Judith A. (2010). Expression of PSA-RP2, an alternatively spliced variant from the PSA gene, is increased in prostate cancer tissues but the protein is not secreted from prostate cancer cells. IKS 2009: 3rd International Symposium on Kallikreins and Kallikrein-Related Peptidases, Munich, Germany, 30 August-2 September 2009. Berlin, Germany: Walter de Gruyter. doi: 10.1515/BC.2010.043 |
|
2010 Journal Article Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extensionSamaratunga, Hemamali, Duffy, David, Yaxley, John and Delahunt, Brett (2010). Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension. Human Pathology, 41 (2), 281-285. doi: 10.1016/j.humpath.2009.08.010 |
|
2010 Journal Article Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profilesGobbo, Stefano, Eble, John N., Delahunt, Brett, Grignon, David J., Samaratunga, Hemamali, Martignoni, Guido, Zhang, Shaobo, Wang, Mingsheng, Brunelli, Matteo, Cossu-Rocca, Paolo and Cheng, Liang (2010). Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profiles. American Journal of Surgical Pathology, 34 (5), 620-626. doi: 10.1097/PAS.0b013e3181d73293 |
|
2010 Journal Article Comparative biomarker expression and RNA integrity in biospecimens derived from radical retropubic and robot-assisted laparoscopic prostatectomiesRicciardelli, Carmela, Bianco-Miotto, Tina, Jindal, Shalini, Dodd, Thomas J., Cohen, Penelope A., Marshall, Villis R., Sutherland, Peter D., Samaratunga, Hemamali, Kench, James G., Dong, Ying, Wang, Hong, Clements, Judith A., Risbridger, Gail P., Sutherland, Robert L., Tilley, Wayne D. and Horsfall, David J. (2010). Comparative biomarker expression and RNA integrity in biospecimens derived from radical retropubic and robot-assisted laparoscopic prostatectomies. Cancer Epidemiology Biomarkers and Prevention, 19 (7), 1755-1765. doi: 10.1158/1055-9965.EPI-10-0059 |
|
2010 Journal Article Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: Implications for clinical managementAydin, Hakan, Zhang, Jun, Samaratunga, Hemamali, Tan, Nelly, Magi-Galluzzi, Cristina, Klein, Eric, Jones, J. Stephen and Zhou, Ming (2010). Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: Implications for clinical management. BJU International, 105 (4), 476-480. doi: 10.1111/j.1464-410X.2009.08812.x |
|
2010 Conference Publication Multiple markers in prostate cancer detection in ejaculateTeng, L., Buck, M., Hancock, J., Clarke, R., Samaratunga, H., Schirra, H., Zenzmaier, C., Berger, P., Catto, J., Yaxley, J., Gianduzzo, T., Coughlin, G., Lavin, M. and Gardiner, R. (2010). Multiple markers in prostate cancer detection in ejaculate. URS, USANZ Meeting 2010, Nelson, New Zealand, 10-12 November, 2010. |
|
2009 Journal Article New genomic structure for prostate cancer specific gene PCA3 within BMCC1: implications for prostate cancer detection and progression.Clarke, Raymond A., Zhao, Zhongming, Guo, An-Yuan, Roper, Kathrein, Teng, Linda, Fang Zhi-Ming, Samaratunga, Hema, Lavin, Martin F. and Gardiner, Robert A. (2009). New genomic structure for prostate cancer specific gene PCA3 within BMCC1: implications for prostate cancer detection and progression.. PLoS One, 4 (3) e4995, e4995. doi: 10.1371/journal.pone.0004995 |
|
2009 Conference Publication Prostatic Ductal Adenocarcinoma Diagnosed on Transurethral Biopsy or Transurethral Resection of the Prostate (TURP) Is Not Always Clinically Aggressive DiseaseAydin, H., Zhang, J., Samaratunga, H., Magi-Galluzzi, C. and Zhou, M. (2009). Prostatic Ductal Adenocarcinoma Diagnosed on Transurethral Biopsy or Transurethral Resection of the Prostate (TURP) Is Not Always Clinically Aggressive Disease. 98th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Boston Ma, Mar 07-13, 2009. NEW YORK: NATURE PUBLISHING GROUP. |
|
2009 Conference Publication Correlation of Conventional and Modified Gleason Grading of Prostatic Adenocarcinoma after Radical ProstatectomySamaratunga, H., Delahunt, B., Duffy, D. and Yaxley, J. (2009). Correlation of Conventional and Modified Gleason Grading of Prostatic Adenocarcinoma after Radical Prostatectomy. 98th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Boston, MA, United States, Mar 07-13, 2009. NEW YORK: NATURE PUBLISHING GROUP. |
|
2008 Journal Article Ductal adenocarcinoma of the prostate - Current opinion and controversiesSamaratunga, Hemamali and Delahunt, Brett (2008). Ductal adenocarcinoma of the prostate - Current opinion and controversies. Analytical and Quantitative Cytology and Histology, 30 (4), 237-246. |
|
2008 Journal Article Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutationWillems, Amber J., Dawson, Sarah -J., Samaratunga, Hema, De Luca, Alessandro, Antill, Yoland C., Hopper, John L. and Thorne, Heather J. (2008). Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation. Clinical Cancer Research, 14 (10), 2953-2961. doi: 10.1158/1078-0432.CCR-07-5237 |
|
2008 Journal Article Kallikrein-related peptidase 4( KLK4)initiates intracellular signaling via protease-activated receptors(PARs):KLK4 and PAR-2 are co-expressed during prostate cancer progressionRamsay, Andrew J., Dong, Ying, Hunt, Melanie L., Linn, MayLa, Samaratunga, Hemamali, Clements, Judith A. and Hooper, John D. (2008). Kallikrein-related peptidase 4( KLK4)initiates intracellular signaling via protease-activated receptors(PARs):KLK4 and PAR-2 are co-expressed during prostate cancer progression. The Journal of Biological Chemistry, 283 (18), 12293-12304. doi: 10.1074/jbc.M709493200 |
|
2008 Conference Publication Hybrid tumors in renal oncocytosis: the missing link between oncocytoma and chromophobe renal cell carcinoma?Cheng, Liang, Gobbo, Stefano, Eccher, Albino, Eble, John, Delahunt, Brett, Grignon, David, Samaratunga, Hemamali, Martignoni, Guido, Zhang, Shaobo, Wang, Mingsheng, Cossu-Rocca, Paolo and Brunelli, Matteo (2008). Hybrid tumors in renal oncocytosis: the missing link between oncocytoma and chromophobe renal cell carcinoma?. NEW YORK: SPRINGER. |
|
2008 Journal Article A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locusMyers, Stephen A., Kaushal, Aneel, Dong, Ying, Lai, John, Tan, Olivia L., Bui, Loan T., Hunt, Melanie L., Digby, Matthew R., Samaratunga, Hemamali, Gardiner, Robert A., Clements, Judith A. and Hooper, John D. (2008). A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus. Prostate, 68 (4), 381-399. doi: 10.1002/pros.20685 |
|
2008 Journal Article Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic functionDong, Ying, Matigian, Nick, Harvey, Tracey J., Samaratunga, Hemamali, Hooper, John D. and Clements, Judith A. (2008). Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic function. Biological Chemistry, 389 (2), 99-109. doi: 10.1515/BC.2008.013 |
|
2008 Conference Publication Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened populationSamaratunga, H., Delahun, B., Duffy, D. and Yaxley, J. (2008). Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened population. 97th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Denver CO, United States, Mar 01-07, 2008. London, United Kingdom: Nature Publishing Group. |
|
2008 Journal Article What is the molecular pathology of low-risk prostate cancer?Samaratunga, Hemamali and Epstein, Jonathan I. (2008). What is the molecular pathology of low-risk prostate cancer?. World Journal of Urology, 26 (5), 431-436. doi: 10.1007/s00345-008-0260-5 |
|
2008 Conference Publication Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened populationSamaratunga, H., Delahunt, B., Duffy, D. and Yaxley, J. (2008). Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened population. 97th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Denver Co, Mar 01-07, 2008. NEW YORK: NATURE PUBLISHING GROUP. |
|
2008 Journal Article Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancerKelly Anne Landers, Samaratunga, Hemamali, Linda Teng, Buck, M., Burger, Michelle J., Betty Scells, Lavin, Martin F. and Gardiner, Robert A. (2008). Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer. British Journal of Cancer, 99 (3), 491-501. doi: 10.1038/sj.bjc.6604486 |
